El.En (ELN) El.En.: la bella addormentata con oltre 60 milioni di "dote"...
- Creatore Discussione Spotti
- Data di Inizio
vincislato
Forumer attivo
certo che se facesse qualche comunicato ogni tanto anche el.en...
(CYNo al momento +3%)
Cynosure (NASDAQ: CYNO) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SculpSure™ for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.
SculpSure is a safe, clinically proven treatment designed to reduce fat non-invasively by disrupting subcutaneous fat cells. The versatile, hands-free device features a flexible applicator system to treat multiple anatomical areas of the body. SculpSure, which uses a 1060 nm laser, can treat an anatomical area in approximately 25 minutes. Patients are able to achieve desired results without downtime or surgery. The technology is expected to be launched in the U.S. in the second half of 2015.
"SculpSure is the world's first hyperthermic laser treatment for the non-invasive reduction of fat from the abdomen," said plastic surgeon Dr. Lawrence S. Bass, M.D., of Bass Plastic Surgery PLLC, who participated in the clinical evaluation of SculpSure. "Subjects in our study saw a statistically significant reduction in adipose layer thickness, with more than 90% reporting they were satisfied with the treatment."
Cynosure CEO Michael Davin said, "The abdomen and flanks are two areas of the body that are often difficult to target with diet and exercise alone, so the fact that SculpSure can now effectively treat both of these regions is great news for consumers. It's also a significant achievement for our Company, demonstrating the initial breadth of our non-invasive fat reduction platform. We believe that SculpSure's versatility and fast treatment time are key competitive advantages that will drive demand for the technology among aesthetic practitioners and their patients."
(CYNo al momento +3%)
Cynosure (NASDAQ: CYNO) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market SculpSure™ for non-invasive lipolysis of the abdomen. In May, the FDA cleared SculpSure for non-invasive lipolysis of the flanks.
SculpSure is a safe, clinically proven treatment designed to reduce fat non-invasively by disrupting subcutaneous fat cells. The versatile, hands-free device features a flexible applicator system to treat multiple anatomical areas of the body. SculpSure, which uses a 1060 nm laser, can treat an anatomical area in approximately 25 minutes. Patients are able to achieve desired results without downtime or surgery. The technology is expected to be launched in the U.S. in the second half of 2015.
"SculpSure is the world's first hyperthermic laser treatment for the non-invasive reduction of fat from the abdomen," said plastic surgeon Dr. Lawrence S. Bass, M.D., of Bass Plastic Surgery PLLC, who participated in the clinical evaluation of SculpSure. "Subjects in our study saw a statistically significant reduction in adipose layer thickness, with more than 90% reporting they were satisfied with the treatment."
Cynosure CEO Michael Davin said, "The abdomen and flanks are two areas of the body that are often difficult to target with diet and exercise alone, so the fact that SculpSure can now effectively treat both of these regions is great news for consumers. It's also a significant achievement for our Company, demonstrating the initial breadth of our non-invasive fat reduction platform. We believe that SculpSure's versatility and fast treatment time are key competitive advantages that will drive demand for the technology among aesthetic practitioners and their patients."
franci63
Forumer storico
Intanto Cynosure si è riportata sulla soglia dei 39$ nonostante la giornata negativa di borsa...
peccato che noi abbiamo in ptf el en
Spotti
.
peccato che noi abbiamo in ptf el en
In queste situazioni bisogna guardare il bicchiere mezzo pieno e consolarsi per il fatto di possedere in portafoglio aziende sane, solide, che generano utili e cassa...
...altrimenti meglio vendere tutto ed andare in vacanza (sperando al rientro di non ritrovarsi qualche brutta sorpresa...)
franci63
Forumer storico
Intanto Cynosure si è riportata sulla soglia dei 39$ nonostante la giornata negativa di borsa...
rotti i 40......speriamo di seguire a ruota
Spotti
.
Franci, sei sempre troppo impulsivo!
Fai bene ad accumulare ma non devi avere fretta come al solito...
Per investire 1 mil. così è di certo qualcuno informato molto bene del settore
Solo perché non conosci la "pancia" di Franci...
P.S.
Quando tra un paio di giorni avrai perso la pazienza, evita almeno di metterne trentamila in vendita a 35€...
Ultima modifica:
franci63
Forumer storico
Franci, sei sempre troppo impulsivo!
Fai bene ad accumulare ma non devi avere fretta come al solito.
Solo perché non conosci la "pancia" di Franci...
P.S.
Quando tra un paio di giorni avrai perso la pazienza, evita almeno di metterne trentamila in vendita a 35€...
sempre voglia di scherzare il buon Spotti
......sai che io sono un pesce piccolo
.....una volta in borsa ero un bel tonno...ora mi sono ridotto a un aringa
. Cerco di seguire i tuoi consigli x cercare di tornare almeno un merluzzo
ma la mia impulsivita' mi gioca sempre brutti scherzi
.......vedi ultime caz..zate con csp e trevi vendute in loss sui minimifranci63
Forumer storico
Similar threads
